Illumina

Illumina, Inc. is a prominent biotechnology company based in San Diego, California, founded in April 1998. The company specializes in developing and marketing integrated systems for genetic analysis, focusing on sequencing, genotyping, and gene expression profiling. Illumina's technology supports a wide range of applications in life sciences and molecular diagnostics, enabling the analysis of genetic variation and biological function.

The company offers advanced DNA sequencing platforms, including the HiSeq and NovaSeq series, which have significantly reduced costs and increased throughput for genome sequencing. Illumina's proprietary sequencing by synthesis (SBS) chemistry enhances accuracy and efficiency, making whole-genome sequencing more accessible. Their product offerings also include solutions for multiomics, copy number variation analysis, DNA methylation analysis, and real-time PCR.

Illumina operates through two main segments: Life Sciences and Diagnostics. The Life Sciences segment provides tools for DNA sequencing and gene expression analysis, while the Diagnostics segment focuses on molecular diagnostic products. With a diverse customer base that includes genomic research institutes, pharmaceutical companies, and healthcare providers, Illumina plays a vital role in advancing genomics and healthcare worldwide.